Drugmakers seek FDA emergency authorization for molnupiravir, antiviral pill to treat COVID-19: Latest updates
Merck & Co. and Ridgeback Biotherapeutics announced Monday the submission of emergency use authorization to the FDA for molnupiravir. COVID updates.
from USATODAY - News Top Stories https://ift.tt/3lsiSbZ
Merck & Co. and Ridgeback Biotherapeutics announced Monday the submission of emergency use authorization to the FDA for molnupiravir. COVID updates.
October 11, 2021 at 11:40AM https://ift.tt/3Bvaxde https://ift.tt/3lsiSbZ
Post a Comment